Shares of Abbott Laboratories (ABT) - Get Abbott Laboratories Report are higher Wednesday after the company posted better-than-anticipated earnings for the third quarter. The medical device company reported earnings of $0.59 a share, exceeding analysts' forecasts by about $0.01. Revenue for the period was $5.3 billion, in line with Wall Street's expectations. For 2016, Abbott now sees earnings of between $2.19 and $2.21 a share versus its prior view for earnings of $2.14 to $2.24 a share. Analysts are projecting earnings of $2.20 a share for the full year.
Employees of TheStreet are restricted from owning individual securities.